The benefits from treatment with antivenom sera are indubitable. However, the mechanism for toxin neutralization has not been completely elucidated. A mixture of anti-bothropic and anti-crotalic horse antivenom has been reported to be more effective in neutralizing the effects of B. jararacussu snake venom than anti-bothropic antivenom alone. This study determined which regions in the three PLA 2 s from B.jararacussu snake venom are bound by antibodies in tetravalent anti-bothropic and monovalent anti-crotalic commercial horse antivenom.
Background
The benefits from treatment with antivenom sera are indubitable. However, the mechanism for toxin neutralization has not been completely elucidated. A mixture of anti-bothropic and anti-crotalic horse antivenom has been reported to be more effective in neutralizing the effects of B. jararacussu snake venom than anti-bothropic antivenom alone. This study determined which regions in the three PLA 2 s from B.jararacussu snake venom are bound by antibodies in tetravalent anti-bothropic and monovalent anti-crotalic commercial horse antivenom.
Methods
The epitopes recognized by therapeutic horse antivenom sera in the three major PLA 2 s present in the venom of B. jararacussu, BthTX-I, BthTX-II and BthA-I, were mapped using the parallel Spot-synthesis strategy. Two peptide libraries were designed to more precisely define the epitopes recognized by anti-bothropic and/or anticrotalic horse antivenom. Each consisted of 69 peptide sequences of fourteen amino acids each that overlapped by nine amino acids and covered the entire protein sequences of the three PLA 2 s. The oligomeric structure of PLA 2S proteins were solved by X-ray crystallography and are available in the protein data bank. The sequences of fifty PLA 2 s were selected and grouped into three sub-groups. Shared amino acids sequence from the 12 epitopes recognized by the reaction between the B. jararacussu PLA 2 s and anti-crotalic/anti-bothropic horse antivenom were analyzed by a multiple sequence alignment.
Results and conclusions
Mapping experiments of BthTX-I, BthTX-II and BthA-I using two small libraries of 69 peptides each revealed six major IgG-binding epitopes that were recognized by both anti-bothropic and anti-crotalic horse antivenom. Two epitopes in BthTX-I were only recognized by the anti-bothropic horse antivenom, while anti-crotalic horse antivenom recognized four unique epitopes across the three PLA 2 s. Our studies suggest that the harmful activities of the PLA 2 s present in the venom of B. jararacussu are neutralized by the combinatorial treatment with both antivenom sera through their complementary binding sites, which provides a wide coverage on the PLA 2 s. In conclusion, the peptide arrays formed directly onto cellulose membranes allowed the identification of the major antigenic determinants in the three most important PLA 2 s (BthTX-I, BthTX-II and BthA-I) isolated from B. jararacussu snake venom recognized by commercial antibothropic and anti-crotalic horse antivenom. The crossreactive epitopes located in the Lys49-PLA 2 , the major protein of this venom, recognized two specific epitopes located in a region of the enzyme responsible for the myotoxic action, which contributes to the deleterious effects of snake venom. In addition, the ability of the anti-crotalic horse antivenom to neutralize the anticoagulant activity was most likely associated with the acidic Asp49-PLA 2 . This study provides proof that the mixture of anti-crotalic and anti-bothropic horse antivenom is CDTS/FIOCRUZ, Rio de Janeiro, Rio de Janeiro,22640-180, Brazil qualitatively more effective in neutralizing the effects unleashed of B. jararacussu snakebite. Regions recognized by the protective antivenom sera are prime candidates for improved venom cocktails or a chimeric protein encoding the multiple epitopes to immunize animals as well as for designing future synthetic vaccines.
